Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-014505
Filing Date
2025-04-18
Accepted
2025-04-18 07:30:50
Documents
23
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20042039x1_pre14a.htm   iXBRL PRE 14A 1761794
6 ny20042039x1_graph01.jpg GRAPHIC 145059
7 ny20042039x1_pc01.jpg GRAPHIC 743812
8 ny20042039x1_pc02.jpg GRAPHIC 683136
9 ny20042039x1_piechart01.jpg GRAPHIC 102964
10 ny20042039x1_pvp01.jpg GRAPHIC 177959
11 ny20042039x1_pvp02.jpg GRAPHIC 144551
  Complete submission text file 0001140361-25-014505.txt   7877902

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA advm-20250617.xsd EX-101.SCH 3472
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE advm-20250617_def.xml EX-101.DEF 2777
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE advm-20250617_lab.xml EX-101.LAB 2971
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE advm-20250617_pre.xml EX-101.PRE 6376
25 EXTRACTED XBRL INSTANCE DOCUMENT ny20042039x1_pre14a_htm.xml XML 203245
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36579 | Film No.: 25849231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)